申请人:Tully David C.
公开号:US20080176901A1
公开(公告)日:2008-07-24
The invention provides compounds and pharmaceutical compositions thereof, which are useful for modulating channel activating proteases, and methods for, using such compounds to treat, ameliorate or prevent a condition associated with a channel activating protease, including but not limited to prostasin, PRSS22, TMPRSS11 (e.g., TMPRSS11B, TMPRSS11E), TMPRSS2, TMPRSS3, TMPRSS4 (MTSP-2), matriptase (MTSP-1), CAP2, CAP3, trypsin, cathepsin A, or neutrophil elastase.
该发明提供了化合物及其药物组合物,用于调节通道激活蛋白酶,并使用这些化合物治疗、改善或预防与通道激活蛋白酶相关的疾病的方法,包括但不限于前列腺素酶、PRSS22、TMPRSS11(例如TMPRSS11B、TMPRSS11E)、TMPRSS2、TMPRSS3、TMPRSS4(MTSP-2)、酶蛋白酶(MTSP-1)、CAP2、CAP3、胰蛋白酶、卡特普西蛋白A或中性粒细胞弹性蛋白酶。